Lab of the Future is now

Célia Gasselin

Articles by:Célia Gasselin

Célia joined LabTwin after several years of experience in international research and science communication. After pursuing a PhD in Neurosciences at the French National Institute for Health and Medical Research (INSERM), Célia joined the highly innovative Swiss institution EPFL as a neuroscientist where she performed state-of-the-art in vivo experiments. Here, she was engaged in the full digital transformation of her laboratory with the development and integration of LIMS-ELN and connected devices in her daily routine. It is with deep passion for empowering science efficiency that she joined LabTwin team in their journey to implement the Lab of the Future.

Digital Transformation: How LabTwin Revolutionizes Documentation of Microbiological Testing in cGMP Environments

Everyone expects medicines to be safe and effective. Therefore, regulatory authorities require that drug manufacturing processes follow current Good Manufacturing Practice (cGMP). Microbiological testing commonly occurs at several stages of drug development to ensure that products are not...

Read more

Digital Transformation: How LabTwin accelerates Method Development for Protein Expression

Bringing a new drug on the market is a long and expensive process. Biopharmaceutical companies spend around $1 billion in R&D per therapeutic product and the recent pandemics have highlighted the necessity of accelerating the deployment of new targeted drugs.

Read more

Subscribe to our newsletter

Click me